Huntsman Q1 2026 Loss Widens, Confirming Prolonged Trough

What happened

Huntsman reported a first-quarter 2026 net loss of $53 million, or $0.31 per share, significantly wider than the $5 million loss a year earlier, as pricing pressures persisted across its segments. Adjusted net loss also deepened to $35 million from $19 million, highlighting the ongoing cyclical downturn despite cost-cutting efforts. The results align with the DeepValue report's characterization of an 'extended cyclical trough,' with leverage remaining elevated at ~5.8x net debt/EBITDA and interest coverage negative. While the company's liquidity is solid at ~$1.4 billion, the equity still trades above a conservative DCF estimate of ~$6.30 per share, suggesting the market is pricing in a recovery that fundamentals have yet to confirm. The wider loss reinforces the existing 'WAIT' stance, with no clear catalyst for near-term improvement.

Implication

Investors should continue to monitor for cyclical bottoming signals such as sequential EBITDA improvement and leverage reduction toward 3-3.5x. The current price still offers no margin of safety versus a conservative DCF, so patience is warranted until a clearer recovery path or a cheaper entry point materializes.

Thesis delta

The Q1 2026 results confirm the DeepValue report's 'extended cyclical trough' thesis and deeper-than-anticipated losses, but do not fundamentally alter the WAIT stance. The lack of improvement in earnings and persistent leverage reinforce downside risks, with no new positive catalysts identified. The investment case remains contingent on operational recovery and balance sheet de-risking, neither of which is evident in this quarter's results.